To test if CD38 inhibition affects leukemia growth in AML, we applied the monoclonal antibody daratumumab on a series of different AML cell lines in mono-culture, as well as in co-culture to elaborate putative niche-mediated effects of daratumumab. The gene discussed is CD38; the disease is leukemia.